Volume 28, Issue 6 (8-2020)                   JSSU 2020, 28(6): 2720-2733 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sedighi S, Jokar M H, Moradzadeh M. Hamartomatous Polyposis Syndromes: Management and Surveillance Strategies. JSSU. 2020; 28 (6) :2720-2733
URL: http://jssu.ssu.ac.ir/article-1-5079-en.html
Abstract:   (475 Views)
Introduction: Hamartomatous Polyposis Syndromes (HPS) are a rare group of dominant autosomal inheritance, which is characterized by the development of hamartomatous polyps in the gastrointestinal tract.
 This syndrome included Juvenile Polyposis syndrome (JPS), Peutz-Jeghers syndrome (PJS), and PTEN Hamartoma Tumour Syndrome (PHTS). PTEN Hamartoma Tumour Syndrome (PHTS) itself includes Cowden Syndrome, Bannayan-Riley-Ruvalcaba Syndrome (BRRS), and Proteus Syndrome. Diagnosis of Hamartum polyarthritis syndrome (HPS) is routinely made based on clinical criteria, but sometimes the diagnosis of this syndrome becomes problematic due to the varying severity of clinical symptoms even within a family.Therefore, today, genetic testing of germ-related mutations associated with this disease is used in the diagnosis process. Management strategy of the syndrome is different due to extra-intestinal symptoms and various cancers. Clinical awareness and early diagnosis of HPS is important, so it is recommended to patients and families at risk for genetic counseling and care. Surveillance in children with HPS might prevent intestinal and extra-intestinal disorders, and reduce the risk of intestinal cancer or breast cancer in adults.
Full-Text [PDF 926 kb]   (157 Downloads)    
Type of Study: Review article | Subject: Internal diseases
Received: 2020/02/12 | Accepted: 2020/08/31 | Published: 2020/08/31

Add your comments about this article : Your username or Email:

Send email to the article author

© 2021 All Rights Reserved | SSU_Journals

Designed & Developed by : Yektaweb